- Home
- ROIV vs BLD Comparison
ROIV vs BLD Comparison
Compare ROIV & BLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | BLD |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 12.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | BLD |
|---|---|---|
| Price | $21.70 | $426.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $21.94 | ★ $429.38 |
| AVG Volume (30 Days) | ★ 6.7M | 260.8K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 19.67 |
| Revenue | $20,329,000.00 | ★ $5,236,045,000.00 |
| Revenue This Year | N/A | $2.39 |
| Revenue Next Year | $376.94 | $13.47 |
| P/E Ratio | ★ N/A | $22.16 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $266.26 |
| 52 Week High | $22.45 | $461.49 |
Technical Indicators
Market Signals| Indicator | ROIV | BLD |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 46.50 |
| Support Level | $20.14 | $418.75 |
| Resistance Level | $21.48 | $454.91 |
| Average True Range (ATR) | 0.71 | 14.42 |
| MACD | 0.00 | -1.38 |
| Stochastic Oscillator | 65.96 | 17.02 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BLD TopBuild Corp.
TopBuild Corp is an installer and distributor of insulation products. Its operating segments involve the Installation and Specialty Distribution segment. The installation segment provides insulation installation services nationwide through contractor services business. Speciality Distribution segment distributes building and mechanical insulation, insulation accessories and other building product materials for the residential, commercial, and industrial end markets. The majority of revenue is earned from the installation segment. Its main customers are contractors. Other products include gutters, after-paint, garage doors, fireplaces, and fireproofing and stopping. TopBuild operates majorly in the United States.